BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

12:00 AM
 | 
Aug 31, 2009
 |  BC Week In Review  |  Company News  |  Sales & Marketing

UCB, Novartis sales and marketing update

UCB and Novartis extended to 2014 a co-distribution agreement for cardiovascular drug Provas valsartan in Germany. UCB also received exclusive, German...

Read the full 85 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >